Search

Your search keyword '"Zerbo O"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Zerbo O" Remove constraint Author: "Zerbo O"
207 results on '"Zerbo O"'

Search Results

1. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation

2. Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study.

3. A Genome-Wide Survey of Transgenerational Genetic Effects in Autism

5. Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Cote d'Ivoire, Mali and Senegal

8. Ethique du partenariat dans la recherche en santé dans les pays du Sud : des doctorant-e-s en apprentissage

14. La stigmatisation des PVVIH en Afrique : analyse de ses formes et manifestations au Burkina Faso = HIV/AIDS stigma in Africa : analysis of its forms and manifestations in Burkina Faso

15. Les campagnes communautaires de promotion du dépistage VIH en Afrique de l'Ouest : perception des usagers au Burkina Faso

17. Le conseil post-test encourage-t-il les PVVIH &#224 partager leur statut s&#233rologique? Pratiques et suggestions des conseillers au Burkina Faso

18. WEAD0302: Total Control of Epidemic (TCE) program of Humana People to People: a community driven response to the fight against AIDS

19. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs Zidovudine/single-dose Nevirapine prophylaxis) : the Kesho Bora randomized controlled trial

21. Réduction de la fertilité chez les femmes infectées par le VIH-1 : implications pour la sérosurveillance sentinelle

22. Allaitement et VIH en Afrique de l'Ouest : de l'anthropologie à la santé publique

27. Seroprevalence of syphilis among women attending urban antenatal clinics in Burkina Faso, 1995-8

29. A theme issue by, for, and about Africa [1] (multiple letters)

30. Associations between mode of HIV testing and consent, confidentiality, and referral: a comparative analysis in four African countries.

31. Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States.

32. Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study.

33. Trends in Gonorrhea and Chlamydia Testing and Infections Across the COVID-19 Pandemic in Adolescents and Young Adults in an Integrated Health System.

34. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.

35. Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children.

36. HIV testing among female sex workers and associated factors in Burkina Faso: findings from a respondent-driven sampling survey.

37. Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies.

38. Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022-August 2023.

39. COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births.

40. Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023.

41. Cost-effectiveness analysis of community-led HIV self-testing among key populations in Côte d'Ivoire, Mali, and Senegal.

42. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination.

43. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.

44. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.

45. Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.

46. Organisation of testing services, structural barriers and facilitators of routine HIV self-testing during sexually transmitted infection consultations: a qualitative study of patients and providers in Abidjan, Côte d'Ivoire.

47. Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.

48. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.

49. Impact of the COVID-19 Pandemic on Health Care Utilization in the Vaccine Safety Datalink: Retrospective Cohort Study.

50. Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy.

Catalog

Books, media, physical & digital resources